1Salmon P,Skaife K,Rhodes J.Abuse,dissociation,and somatization in irritable bowel syndrome:towards an explanatory model.J Behav Med,2003,26( 1 ): 1-18.
2Kane SV,Sandborn WJ,Rufo PA,et al. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation.Am J Gastroenterol,2003,98(6): 1309-1314.
3Drossman DA.The funtional gastrointestinal disorders and the Rome Ⅱ process. Gut, 1999,45(Suppl Ⅱ ): Ⅱ 1- Ⅱ 5.
4Kohli,R,Li BU.Differential diagnosis of recurrent abdominal pain: new considerations. Pediatr Ann, 2004,33 (2): 113-122.
5Muller LS,Koch G,Talley NJ,et al. Subject's global assessment of relief:an appropriate method to assess the impact of treatment on irritable bowel syndrome - related symptoms in clinical trials.J Clin Epidemiol,2003,56(4) :310-316.
6Blanchard EB,Scharff L. Psychosocial aspects of assessment and treatment of irritable bowel syndrome in adults and recurrent abdominal pain in children.J Consult Clin Psychol, 2002,70(3) :725-738.
